Gene Therapy Market
The Gene Therapy market is projected to grow from USD 8.6 billion in 2023-e to USD 32.4 billion by 2030, registering a CAGR of 20.9% during the forecast period. The Gene Therapy market is dominated by key players such as Novartis, Uniqure, Johnson & Johnson, Orchard Therapeutics, Biogen, Gilead Sciences, Bristol-Myers Squibb, and Sarepta Therapeutics.